Your browser doesn't support javascript.
loading
Microbiological Profile of Fracture Related Infection at a UK Major Trauma Centre.
Patel, Kavi H; Gill, Laura I; Tissingh, Elizabeth K; Galanis, Athanasios; Hadjihannas, Ioannis; Iliadis, Alexis D; Heidari, Nima; Cherian, Benny; Rosmarin, Caryn; Vris, Alexandros.
Afiliação
  • Patel KH; Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Gill LI; Department of Infection, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Tissingh EK; Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Galanis A; KAT General Hospital, Nikis 2, 14561 Kifisia, Greece.
  • Hadjihannas I; Barts and the London School of Medicine, Garrod Building, Turner St., London E1 2AD, UK.
  • Iliadis AD; Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Heidari N; Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Cherian B; Department of Infection, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Rosmarin C; Department of Infection, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
  • Vris A; Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
Antibiotics (Basel) ; 12(9)2023 Aug 24.
Article em En | MEDLINE | ID: mdl-37760655
ABSTRACT
Fracture Related Infection (FRI) represents one of the biggest challenges for Trauma and Orthopaedic surgery. A better understanding of the microbiological profile should assist with decision-making and optimising outcomes. Our primary aim was to report on the microbiological profile of FRI cases treated over a six-year period at one of Europe's busiest trauma centres. Secondarily, we sought to correlate our findings with existing anti-microbiological protocols and report on diagnostic techniques employed in our practice. All adult cases of FRI treated in our institution between 2016 and 2021 were identified, retrospectively. We recorded patient demographics, diagnostic strategies, causative organisms and antibiotic susceptibilities. There were 330 infection episodes in 294 patients. A total of 463 potentially pathogenic organisms (78 different species) were identified from cultures, of which 57.2% were gram-positive and 39.7% gram-negative. Polymicrobial cultures were found in 33.6% of cases and no causative organism was found in 17.5%. The most prevalent organisms were Staphylococcus aureus (24.4%), coagulase-negative Staphylococci (14%), Pseudomonas aeruginosa (8.2%), Enterobacter species (7.8%) and Escherichia coli (6.9%). Resistant gram-positive organisms (methicillin resistant Staphylococcus aureus or vancomycin-resistant Enterococci) were implicated in 3.3% of infection episodes and resistant gram-negatives (extended-spectrum beta-lactamase, ampC or carbapenemase-producing bacteria) in 13.6%. The organisms cultured in 96.3% of infection episodes would have been covered by our empirical systemic antibiotic choice of teicoplanin and meropenem. To our knowledge, this is the largest reported single-centre cohort of FRIs from a major trauma centre. Our results demonstrate patterns in microbiological profiles that should serve to inform the decision-making process regarding antibiotic choices for both prophylaxis and treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article